Basmina Parmakhtiar

Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture

Valerie Trapp, Basmina Parmakhtiar, Vartan Papazian et al. · Angiogenesis · 2010 · 115 citations · Full text

Medicine, Cancer Biology, Oncology +16

Lycopene Enhances Docetaxel's Effect in Castration-Resistant Prostate Cancer Associated with Insulin-like Growth Factor I Receptor Levels

Yaxiong Tang, Basmina Parmakhtiar, Anne R. Simoneau et al. · Neoplasia · 2011 · 88 citations · Full text

Medicine, Oncology, Pharmacology +16

Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer

Ernest Han, Robert A. Burger, Kathleen M. Darcy et al. · Gynecologic Oncology · 2010 · 63 citations · Full text

Medicine, Gynecology, Oncology +16

HIF Inactivation of p53 in Ovarian Cancer Can Be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity

Basmina Parmakhtiar, Robert A. Burger, Jai-Hyun Kim et al. · Molecular Cancer Research · 2019 · 42 citations

Medicine, Oncology, Pharmacology +16

Phase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma

John P. Fruehauf, Monica El‐Masry, K. Osann et al. · Cancer Chemotherapy and Pharmacology · 2018 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17